Lawrence Cohen, CEO of Glycotest, presented at Net Scientific’s June 2016 Capital Markets Day.
Related News
Other posts that you should not miss.
New York, NY—November 21, 2019. Glycotest, Inc., a diagnostics company commercializing new and unique blood tests for life threatening liver cancers and fibrosis–cirrhosis, announced today that the Company has received the second $3 million tranche of the $10 million Series A funding round from Shanghai Fosun Pharmaceutical Co., Ltd. (“Fosun Pharma”). The focus of this [...]
Glycotest19-CEOCFOMagazine-Interview.pdf
MedTech Innovator Showcase Announcement 6.17.19
Lawrence Cohen, CEO of Glycotest, presented at Net Scientific’s June 2016 Capital Markets Day. | Glycotest Diagnostics